With SpectraCann’s THC breathalyzer, you will know – on the spot, in seconds!
Our THC Breathalyzer provides companies with data needed to appropriately implement their safety policies and procedures.
Immediate and accurate results mean people who are ready to work can proceed to the jobsite without delay.
Our THC Breathalyzer provides companies with data needed to appropriately implement their safety policies and procedures.
- Improve Workplace Safety.
- Maximize Productivity (Keep people working, reduce wait times).
- Help ensure people come home safely to their families - every day.
Receive relevant information needed to make important decisions.
- Narrow Window of Detection - 1-3 hours from consumption
- Measures active THC – the psychoactive compound in cannabis
Immediate and accurate results mean people who are ready to work can proceed to the jobsite without delay.
An all-in-one solution that facilitates testing anywhere, anytime.
Our THC Breathalyzer provides a convenient and efficient approach for drug screening programs in different settings.
The use of THC Breathalyzer Devices enables law enforcement officers to effectively measure THC influence during traffic stops and DUI checkpoints. Unlike traditional testing methods that rely on blood or urine samples, our breathalyzer provides immediate and on-site results. This streamlines the process, allowing law enforcement to promptly get the information they need to make important decisions.
Participate in our pilot program and contribute to safer workplaces and communities. We’re seeking organizations interested in evaluating our technology and providing feedback on their experience.
Join Us in Making a Difference.
SpectraCann, founded in 2022 in Edmonton, Alberta, Canada, aims to solve the primary drug testing problem of – slow, inaccurate, irrelevant data needed to make important decisions in the field.
Having developed the world’s first quantum molecular breathalyzer for THC and other drugs, we can now address the needs of industry and law enforcement.
SpectraCann, founded in 2022 in Edmonton, Alberta, Canada, aims to solve the primary drug testing problem of – slow, inaccurate, irrelevant data needed to make important decisions in the field.
Having developed the world’s first quantum molecular breathalyzer for THC and other drugs, we can now address the needs of industry and law enforcement.
At SpectraCann, we believe quantum physics and cloud computing have the power to revolutionize the field of drug testing.
At SpectraCann, we understand the dynamic nature of drug use trends in society. As the landscape of drug usage continues to evolve, our innovative breathalyzer is designed to adjust and provide adaptable solutions to address these changing patterns effectively.
SpectraCann’s team of experts is actively working to bring our THC Breathalyzer to market and will soon develop full-spectrum drug testing including fentanyl, cocaine and other illicit and prescription drugs.
The potential use cases of our technology are vast and our team is ready to embark on this exciting journey.
Our Team
CEO & Co-Founder
COO & Co-Founder
CTO & Co-Founder